STRIDES PHARMA SCIENCE Fact Sheet, STRIDES PHARMA SCIENCE Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Fact Sheet    (PLLB)


LIVE on April 23rd: Has Covid impacted India's long-term growth potential?


Here is the latest financial fact sheet of STRIDES PHARMA SCIENCE. For more details, see the STRIDES PHARMA SCIENCE quarterly results and STRIDES PHARMA SCIENCE share price and chart. For a sector overview, read our pharmaceuticals sector report.

STRIDES PHARMA SCIENCE Price History

Price Rs 913.8
Mkt Cap Rs m 54,508
Vol '000 111.5
P/E X 47.6
P/CF X 22.6
EPS (TTM) Rs 19.2
% ch % 1.5
No. of shares m 59.65
% ch week % 4.3
% ch 1-mth % 13.9
% ch 12-mth % 169.2
52 week H/L Rs 1,000.0/322.0
(As on Apr 22, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

STRIDES PHARMA SCIENCE Financials

No. of Mths
Year Ending
15
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
STRIDES PHARMA SCIENCE EQUITY SHARE DATA
High Rs1,1381,1991,4131,2751,147 
Low Rs344384848918642 
Sales per share (Unadj.) Rs225.1200.6320.3308.1317.2 
Earnings per share (Unadj.) Rs296.6141.713.231.37.8 
Diluted earnings per shareRs296.2141.719.846.911.8 
Cash flow per share (Unadj.) Rs306.1152.527.945.425.1 
Dividends per share (Unadj.) Rs505.00108.005.004.502.00 
Adj. dividends per shareRs504.32107.957.496.753.00 
Dividend yield (eoy) %68.213.70.40.40.2 
Book value per share (Unadj.) Rs169.0193.9297.5307.4274.3 
Adj. book value per shareRs168.8193.8445.6460.8411.5 
Shares outstanding (eoy) m59.5759.6289.3589.4289.50 
Bonus/Rights/Conversions  ESOPESOPESOPESOPESOP 
Price / Sales ratio x3.33.93.53.62.8 
Avg P/E ratio x2.55.685.535.1114.0 
P/CF ratio (eoy) x2.45.240.524.235.7 
Price / Book Value ratio x4.44.13.83.63.3 
Dividend payout %170.376.237.814.425.5 
Avg Mkt Cap Rs m44,13547,165100,98898,03680,058 
No. of employees `0001.52.04.75.82.5 
Total wages/salary Rs m1,5721,7213,5774,1924,341 
Avg. sales/employee Rs Th8,939.55,979.36,102.84,750.811,325.8 
Avg. wages/employee Rs Th1,047.9860.3762.7722.71,731.4 
Avg. net profit/employee Rs Th11,778.34,225.0251.9482.2280.1 
STRIDES PHARMA SCIENCE INCOME DATA
Net Sales Rs m13,40911,95928,62227,55428,394 
Other income Rs m6023869211,611941 
Total revenues Rs m14,01212,34429,54329,16529,334 
Gross profit Rs m2,2342,2894,1405,2743,965 
Depreciation Rs m5656401,3131,2621,540 
Interest Rs m1,0894741,6821,8311,962 
Profit before tax Rs m1,1831,5602,0673,7921,403 
Minority Interest Rs m-66000 
Prior Period Items Rs m00-474-168 
Extraordinary Inc (Exp) Rs m19,7368,361-414-364-436 
Tax Rs m3,2451,47642563497 
Profit after tax Rs m17,6678,4501,1812,797702 
Gross profit margin %16.719.114.519.114.0 
Effective tax rate %274.394.620.516.76.9 
Net profit margin %131.870.74.110.22.5 
STRIDES PHARMA SCIENCE BALANCE SHEET DATA
Current assets Rs m13,08614,44735,14937,91824,836 
Current liabilities Rs m7,07410,02218,92031,03918,993 
Net working cap to sales %44.837.056.725.020.6 
Current ratio x1.81.41.91.21.3 
Inventory Days Days4863789771 
Debtors Days Days99112132132113 
Net fixed assets Rs m5,5068,40035,68237,63934,289 
Share capital Rs m596596894894895 
"Free" reserves Rs m4,59410,96225,68526,59423,651 
Net worth Rs m10,06811,55826,57927,48824,546 
Long term debt Rs m2,7552,53026,27016,37715,513 
Total assets Rs m20,99024,80574,55981,05065,437 
Interest coverage x2.14.32.23.11.7 
Debt to equity ratio x0.30.21.00.60.6 
Sales to assets ratio x0.60.50.40.30.4 
Return on assets %89.436.03.85.74.1 
Return on equity %175.573.14.410.22.9 
Return on capital %171.673.86.212.06.9 
Exports to sales %59.460.253.100 
Imports to sales %20.523.515.900 
Exports (fob) Rs m7,9597,20415,19200 
Imports (cif) Rs m2,7522,8094,56500 
Fx inflow Rs m22,79113,03116,61213,46515,697 
Fx outflow Rs m3,0883,1655,2924,076735 
Net fx Rs m19,7039,86511,3209,38914,962 
STRIDES PHARMA SCIENCE CASH FLOW
From Operations Rs m -2,717 834 733 2,881 1,871 
From Investments Rs m 40,771 519 -22,248 -6,867 5,826 
From Financial Activity Rs m -33,185 -4,213 29,439 3,382 -10,157 
Net Cashflow Rs m 4,869 -2,860 7,924 -603 -2,615 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 27.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 37.8%
FIIs 8.6%
ADR/GDR 0.0%
Free float 25.9%
Shareholders 56,241
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 201, Devavrata, Sector 17, Vashi, Navi Mumbai - 400 705
E-MAIL badree.komandur@stridesarco.com WEB www.stridesarco.com
TELEPHONE (080) 6784 0000 FAX (080) 6784 0800
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Deloitte Haskins & Sells
CHM: Deepak Vaidya (MD) COMP SEC: Badree Komandur (EVP-Finance) YEAR OF INC: 1980 BSE CODE: 532531 FV (Rs): 10 DIV YIELD (%): 0.3

Read: STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   ORCHID PHARMA  LUPIN  FRESENIUS KABI ONCO.  SANOFI INDIA  JUBILANT PHARMOVA   

Compare STRIDES PHARMA SCIENCE With:   ORCHID PHARMA  LUPIN  FRESENIUS KABI ONCO.  SANOFI INDIA  JUBILANT PHARMOVA   

Compare STRIDES PHARMA SCIENCE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex, Nifty Recover From Day's Low to End Strong; JSW Steel and ICICI Bank Among Top Nifty Gainers(Closing)

Indian share markets recouped early losses during afternoon deals and ended today's volatile session higher.

Views on news

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY21); Net Profit Down 46.4% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 621 m (down 46.4% YoY). Sales on the other hand came in at Rs 8 bn (up 13.6% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY21); Net Profit Up 184.5% (Quarterly Result Update)

Aug 20, 2020 | Updated on Aug 20, 2020

For the quarter ended June 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 1 bn (up 184.5% YoY). Sales on the other hand came in at Rs 8 bn (up 14.0% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

Top 3 Nifty ETFs to Buy Now (Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE - STERLING BIOTECH COMPARISON

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS